Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cervical cord FMRI abnormalities differ between the progressive forms of multiple sclerosis.
The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination.
Proceedings of the 6th Dubrovnik International Conference on Multiple Sclerosis, 10-12 May 2012, Dubrovnik, Croatia.
Unmet needs of people with severe multiple sclerosis and their carers: qualitative findings for a home-based intervention.
Current role of chemotherapy and bone marrow transplantation in multiple sclerosis.
Bone mineral density levels in adults with multiple sclerosis: A meta-analysis.
New opportunities of real world data from clinical routine settings in life cycle-management of drugs: example of an integrative approach in multiple sclerosis.
Characteristics in childhood and adolescence associated with future multiple sclerosis risk in men: cohort study.
Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.
[Analysis of a series of cases with an initial diagnosis of acute disseminated encephalomyelitis over the period 2000-2010].
Outcomes after Microvascular Decompression for Patients with Trigeminal Neuralgia and Suspected Multiple Sclerosis.
Late-onset multiple sclerosis in South-East wales.
Fulminant inflammatory demyelination: long-term course and magnetic resonance imaging findings.
Pseudobulbar affect: prevalence and management.
Advances in the management of MS symptoms: recently proposed clinical management algorithms.
Nudging Oligodendrocyte Intrinsic Signaling to Remyelinate and Repair: Estrogen Receptor Ligand Effects.
First case report of acute hemorrhagic leukoencephalitis following Plasmodium vivax infection.
Selective accumulation of pro-inflammatory T cells in the intestine contributes to the resistance to autoimmune demyelinating disease.
[Hepatitis B vaccination and multiple sclerosis: From medical uncertainty to compensation for victims.]
Development of [(3)H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([(3)H]PSB-12150): A Useful Tool for Studying GPR17.
Detection of olfactory dysfunction using olfactory event related potentials in young patients with multiple sclerosis.
Multiple sclerosis: Benefits of q-space imaging in evaluation of normal-appearing and periplaque white matter.
Modeling the course and outcomes of multiple sclerosis is statistical twaddle-Yes.
Dimethyl Fumarate Modulation of Immune and Antioxidant Responses: Application to HIV Therapy.
Serum analysis by 1H Nuclear Magnetic Resonance spectroscopy: a new tool for distinguishing neuromyelitis optica from multiple sclerosis.
Pages
« first
‹ previous
…
583
584
585
586
587
588
589
590
591
…
next ›
last »